16:47 EDT OS Therapies (OSTX) files $100M mixed securities shelf
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OSTX:
- Promising Phase 2b Results and Regulatory Advancements Drive Buy Rating for OS Therapies
- OS Therapies files to sell 3.76M shares of common stock for holders
- OS Therapies CEO Paul Romness sees ‘huge upside potential’
- OS Therapies hopes to become commercial biotech in early 2026, CEO says
- Romness sees potential FDA approval, PVR as key to OS Therapies stock